Beyond the Merits: Generic Company Defense Strategies
June 29, 2018
Joshua Reisberg
Pharmaceutical Executive
Pharmaceutical Executive published Axinn counsel Josh Reisberg's article, "Beyond the Merits: Generic Company Defense Strategies."
Pharmaceutical Executive published Axinn counsel Josh Reisberg's article, "Beyond the Merits: Generic Company Defense Strategies."